These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10101472)

  • 1. [Mean values of blood pressure and endothelin plasma concentration in patients with chronic renal failure].
    Kocur E; Kidawa Z; Polakowski P; Orszulak-Michalak D; Karpinski J; Rogulski B; Wołkanin P
    Pol Merkur Lekarski; 1998 Sep; 5(27):114-6. PubMed ID: 10101472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endothelin in patients with chronic kidney failure].
    Nĕmecek K; Bártová V; Jáchymová M; Horký K
    Cas Lek Cesk; 1995 Aug; 134(16):511-3. PubMed ID: 7553749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
    Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
    Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
    Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian serum melatonin profiles in patients suffering from chronic renal failure.
    Karasek M; Szuflet A; Chrzanowski W; Zylinska K; Swietoslawski J
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():97-102. PubMed ID: 12019361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between serum leptin and tumor necrosis factor and endothelin in patients with chronic renal failure].
    Zhang DY; Yang LC; Zhang J; Zhang XL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):750-2. PubMed ID: 15585153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors that affect short-term blood pressure variability in patients with chronic renal failure.
    Sakai M; Tamura K; Tanaka Y; Tsurumi Y; Okano Y; Koide Y; Endoh T; Matsushita K; Kihara M; Hirawa N; Toya Y; Tokita Y; Ohnishi T; Umemura S
    Clin Exp Hypertens; 2005; 27(2-3):139-47. PubMed ID: 15835376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 and nitric oxide in patients on chronic hemodialysis.
    Tomić M; Galesić K; Markota I
    Ren Fail; 2008; 30(9):836-42. PubMed ID: 18925520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
    Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin 1/2 levels in healthy blood donors and in hypertensive patients: clinical application.
    Baldys-Waligórska A; Szybinski Z
    Endocr Regul; 1993 Jun; 27(2):83-7. PubMed ID: 8003715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of ambulatory blood pressure monitoring in kidney disease].
    Robles NR; Cancho B; Crespo E; Sanchez Casado E
    Nefrologia; 2001; 21(1):65-70. PubMed ID: 11344964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in patients with chronic renal failure.
    Havlucu Y; Kursat S; Ekmekci C; Celik P; Serter S; Bayturan O; Dinc G
    Respiration; 2007; 74(5):503-10. PubMed ID: 17505128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
    Tucker B; Fabbian F; Giles M; Johnston A; Baker LR
    Clin Nephrol; 1999 Dec; 52(6):377-82. PubMed ID: 10604646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ambulatory supervised cardiac training on arterial hypertension in patients with coronary artery disease and arterial hypertension].
    Kałka D; Sobieszczańska M; Marciniak W; Popielewicz-Kautz A; Markuszewski L; Chorebała A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Jan; 22(127):9-14. PubMed ID: 17477082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are demographic characteristics of hypertensive patients different with renal artery stenosis?].
    Jaboureck O; Mounier-Vehier C; Devos P; Lions C; Dequiedt P; Beregi JP; Carré A
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):828-33. PubMed ID: 11575212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure, left ventricular mass and function in adult patients after successful repair of coarctation of the aorta.
    Trojnarska O; Szyszka A; Ochotny R; Siwińska A; Cieśliński A
    Kardiol Pol; 2003 Oct; 59(10):312-9. PubMed ID: 14618215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.